The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: vancomycin     Quarter: 2016Q3

Total Records: 1,050     Number of Pages: 53

DRUGNAME PT EventCount
VANCOMYCIN SANDOZ Hypovolaemia 1
VANCOMYCIN SANDOZ Multiple organ dysfunction syndrome 1
VANCOMYCIN SANDOZ Necrotising enterocolitis neonatal 1
VANCOMYCIN SANDOZ Nephropathy toxic 1
VANCOMYCIN SANDOZ Osteopenia 1
VANCOMYCIN SANDOZ Oxygen saturation decreased 1
VANCOMYCIN SANDOZ Pneumatosis 1
VANCOMYCIN SANDOZ Rash 1
VANCOMYCIN SANDOZ Regurgitation 1
VANCOMYCIN SANDOZ Retinopathy 1
VANCOMYCIN SANDOZ Thrombocytopenia 1
VANCOMYCIN SANDOZ Tryptase increased 1
VANCOMYCIN SANDOZ Tubulointerstitial nephritis 1
VANCOMYCIN, 1 GM AND 5 GM VIALS MYLAN Blood creatinine increased 1
VANCOMYCIN, 1 GM AND 5 GM VIALS MYLAN Drug level above therapeutic 1
VANCOMYCIN, 1 GM AND 5 GM VIALS MYLAN Product measured potency issue 1
VANCOMYCIN, 1500 MG Urticaria 1
VANCOMYCIN, 2 GM Renal failure 1
VANCOMYCIN, 750 MG Pruritus generalised 1
VANCOMYCINE Abdominal abscess 1

Total Records: 1,050     Number of Pages: 53